3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer - Pain -

Sex bias seen in control of cancer pain

Cancer • • PainSep 29, 08

How well pain is managed in people with cancer apparently differs between men and women, new research hints.

Dr. Kristine A. Donovan, of the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, and colleagues examined pain severity and the adequacy of pain management in 131 cancer patients newly referred to a multidisciplinary cancer pain clinic.

Men and women did not differ significantly in terms of worst pain scores, least pain scores, or pain interference. However, average pain in the last week and pain right now were significantly higher in women.

In addition, the average total daily dose of pain-killers was significantly greater for men (130 versus 66 milligrams morphine equivalent value).

Women were also significantly less likely than men to receive prescriptions for high potency opioids (33 percent versus 51 percent).

Women were also significantly more likely than men to report inadequate pain control, as indicated by scores on a standard pain management scale.

These findings, Donovan and colleagues conclude, highlight the need to improve the treatment of pain in cancer patients and to “more closely examine physician and patient-related factors that may hinder adequate pain management.”

SOURCE: The Journal of Pain and Symptom Management, August 2008.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  Two-step treatment improved function and decreased pain severity in veterans

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site